Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Appellate Division, Second Department, Brooklyn, New York.(Photo: David Handschuh/ALM) Appellate Division, Second Department, courthouse in Brooklyn (Photo: David Handschuh/ALM)

Despite a major health insurer’s arguments to the contrary, New York’s Appellate Division, Second Department, has ruled that a pharmaceutical company did not commit fraud or tortiously interfere with the health care contracts involving several chronically ill patients who needed expensive out-of-network treatments.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Jane Wester

Jane Wester is a litigation reporter for the New York Law Journal. Email her at jwester@alm.com or find her on Twitter @janewester.

More from this author


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.